Day One Biopharmaceuticals, Inc. (DAWN)
8.635
+0.72
(+9.03%)
USD |
NASDAQ |
Dec 08, 16:00
8.74
+0.10
(+1.22%)
After-Hours: 20:00
Day One Biopharmaceuticals Shareholders Equity (Quarterly): 450.87M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Mersana Therapeutics, Inc. | -59.54M |
| Iovance Biotherapeutics, Inc. | 702.29M |
| Lantheus Holdings, Inc. | 1.119B |
| iRhythm Technologies, Inc. | 121.89M |
| Perspective Therapeutics, Inc. | 242.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 513.78M |
| Total Liabilities (Quarterly) | 62.91M |
| Debt to Equity Ratio | 0.0064 |
| Current Ratio | 8.677 |
| Net Debt Paydown Yield | -0.07% |